IGM Biosciences, Inc.

NASDAQ:IGMS

16.03 (USD) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Operating Activities:
Net Income -47.902-49.816-60.695-61.989-64.423-59.309-52.576-58.037-58.595-51.894-50.642-44.164-38.714-31.644-24.622-20.27-18.839-17.624-14.815-10.172-10.676-7.47-9.053-6.517-3.571-3.571
Depreciation & Amortization 2.2762.1762.1812.2592.1731.6641.8981.5091.4441.2241.3031.0951.4130.6730.3120.2480.2430.222-1.0221.360.1450.1140.0870.0710.060.06
Deferred Income Tax 00-16.117-2.352-2.312000000.2950.1540.1370.1950.2040.131-0.052-0.30600000000
Stock Based Compensation 8.4287.9229.23711.95414.30911.04711.10910.81611.28611.4998.5486.2125.6095.5042.5822.5941.9551.3230.40.3340.1410.1390.1190.020.0220.022
Change In Working Capital -0.896-2.984-0.6434.743-5.853-4.94-1.6733.324154.383-0.8644.7131.0284.368-3.662-1.8861.5822.98-0.6311.888-6.581.101-1.4332.6270.537-0.307-0.307
Accounts Receivables 00000000000000000000000000
Change In Inventory 00000000000000000000000000
Change In Accounts Payables -0.8022.648-2.5180.526-0.6041.604-0.432-0.519-0.807-1.2441.932-1.965-0.361.0452.4640.6390.478-1.3831.306-0.766-0.41.8210.1310.01700
Other Working Capital -0.094-5.6321.8754.217-5.249-6.544-1.2413.843155.190.382.7812.9934.728-4.707-4.350.9432.5020.7520.582-5.8141.501-3.2542.4960.52-0.307-0.307
Other Non Cash Items 14.5029.91118.0295.2643.0010.5413.3841.9752.7691.1660.8750.8580.8350.6720.6460.640.6360.6291.482-0.322-0.0350.3050.0270.016-0.186-0.186
Operating Cash Flow -37.374-42.417-48.008-40.121-53.105-50.997-37.858-40.413111.287-38.869-34.908-34.817-26.352-28.262-22.764-15.075-13.077-16.387-12.067-15.38-9.324-8.345-6.193-5.889-3.981-3.981
Investing Activities:
Investments In Property Plant And Equipment -1.214-2.484-1.448-3.083-3.913-3.937-2.695-2.711-1.823-2.977-1.763-2.246-3.162-6.073-6.708-6.565-2.524-1.705-0.6-0.589-0.433-0.715-0.357-0.11-0.161-0.161
Acquisitions Net 0.032013.245-22.6322.4121.7057.3681.037182.15900000-57.711000-80000000
Purchases Of Investments -62.238-54.789-89.564-109.784-76.417-89.274-158.393-99.117-242.366-40.146-17.989-62.697-35.673-12.989-44.817-36.445-86.171-41.131-151.127-57.774000000
Sales Maturities Of Investments 87.94465.92476.319132.41674.005163.035142.27798.0860.2272421.618.24458.89358.67372.17554.49585.74271.36580000000
Other Investing Activites 25.738-1.132-13.24522.632-2.412-1.705-7.368-1.037-182.159-16.1264.003-44.86423.88245.68457.71118.05-0.42930.2348-57.774000000
Investing Cash Flow 24.5248.651-14.69319.549-6.32569.824-18.811-3.748-183.962-19.1231.848-46.69920.05839.61120.6511.485-2.95328.529-143.727-58.363-0.433-0.715-0.357-0.11-0.161-0.161
Financing Activities:
Debt Repayment 00000000000000000000000000
Common Stock Issued 0.6480.1910.40244.61769.9520.075217.9870.297217.9870.144.0311.4740.5640.365216.186000-0.001187.163000000
Common Stock Repurchased -0.001000000000-0.137-0.403-0.597-0.418-0.238-0.925-0.5680-0.104000-12.096000
Dividends Paid 00000000000000000000000000
Other Financing Activities -0.033-0.0390.4020.02269.9520.075-217.5050.2970.5440.072-2.541.071-0.033-0.053-0.276-0.917-0.2340.022-1.994224.6549.56910.0335.2418.224.4384.438
Financing Cash Flow 0.6150.1520.40244.63969.9520.0750.4820.297218.5310.0721.4911.071-0.033-0.053215.91-0.917-0.2340.022-1.994224.6549.56910.0335.2418.224.4384.438
Other Information:
Effect Of Forex Changes On Cash 00-0.76400.764000000000000000000000
Net Change In Cash -12.235-33.614-62.29924.06710.52218.902-56.187-43.864145.856-57.92-31.569-80.445-6.32711.296213.796-4.507-16.26412.164-157.788150.90739.8120.973-1.3092.2210.2970.297
Cash At End Of Period 67.26379.498113.112175.411151.344140.822121.92178.107221.97176.115134.035165.604246.049252.376241.0827.28431.79148.05535.891193.67942.7722.961.9873.2961.0750.297